We are live on ! Find out more
AXDX

Accelerate Diagnostics

Delisted

AXDX was delisted on the 14th of May, 2025.

112 hedge funds and large institutions have $311M invested in Accelerate Diagnostics in 2020 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 28 increasing their positions, 36 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

9% less funds holding

Funds holding: 123112 (-11)

22% less repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 36

31% less capital invested

Capital invested by funds: $448M → $311M (-$137M)

58% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 19

63% less call options, than puts

Call options by funds: $1.18M | Put options by funds: $3.18M

Holders
112
Holders Change
-11
Holders Change %
-8.94%
% of All Funds
2.26%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
8
Increased
28
Reduced
36
Closed
19
Calls
$1.18M
Puts
$3.18M
Net Calls
-$2M
Net Calls Change
+$787K

AXDX Hedge Fund Activity: Q3 2020 in Review

112 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q3 2020, worth a combined $311M — down 31% from $448M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of AXDX and 8 opened new positions — a net loss of 11 holders — while 36 trimmed existing stakes and 28 added.

The largest buyer was Chicago Capital, adding an estimated $16.8M. The largest seller was Morgan Stanley, cutting an estimated $4.77M.

  • 112 institutional investors held Accelerate Diagnostics (AXDX) as of Q3 2020, down from 123 in Q2 2020.
  • Funds reported $311M of Accelerate Diagnostics stock for Q3 2020, down 31% quarter-over-quarter.
  • 8 funds opened new Accelerate Diagnostics positions in Q3 2020 and 19 closed out, a net change of -11 holders.
  • The largest Accelerate Diagnostics buyer in Q3 2020 was Chicago Capital, an estimated $16.8M added.
  • The largest Accelerate Diagnostics seller in Q3 2020 was Morgan Stanley, an estimated $4.77M sold.

Based on aggregated 13F filings for Q3 2020.